Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook

More articles from Clinical (Radiobiology/Dosimetry/Safety)

  • Open Access
    Evaluation of safety and dosimetry of 177Lu DOTA-ZOL for therapy of bone metastases
    Rene Fernandez, Elisabeth Eppard, Wencke Lehnert, Luis David Jimenez-Franco, Cristian Soza-Ried, Matias Ceballos, Jessica Ribbeck, Andreas Kluge, Frank Roesch, Marian Meckel, Konstantin Zhernosekov, Vasko Kramer and Horacio Amaral
    Journal of Nuclear Medicine January 8, 2021, jnumed.120.255851; DOI: https://doi.org/10.2967/jnumed.120.255851
  • You have access
    Feasibility of single-time-point dosimetry for radiopharmaceutical therapies
    Xinchi Hou, Julia Brosch, Carlos Uribe, Alessandro Desy, Guido Boning, Jean-Mathieu Beauregard, Anna Celler and Arman Rahmim
    Journal of Nuclear Medicine October 30, 2020, jnumed.120.254656; DOI: https://doi.org/10.2967/jnumed.120.254656
  • You have access
    Deep learning generation of synthetic intermediate projections improves 177Lu SPECT images reconstructed with sparsely acquired projections
    Tobias Ryden, Martijn van Essen, Ida Marin, Johanna Svensson and Peter Bernhardt
    Journal of Nuclear Medicine August 28, 2020, jnumed.120.245548; DOI: https://doi.org/10.2967/jnumed.120.245548
  • You have access
    Dissimilar DNA Damage to Blood Lymphocytes after 177Lu-labeled DOTATOC or PSMA Therapy
    Philipp Ritt, Camille Jobic, Christian Schmidkonz, Torsten Kuwert, Michael Uder and Michael Brand
    Journal of Nuclear Medicine July 31, 2020, jnumed.120.243782; DOI: https://doi.org/10.2967/jnumed.120.243782
SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire